"Virus Replication" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle.
| Descriptor ID |
D014779
|
| MeSH Number(s) |
G06.920.925
|
| Concept/Terms |
Virus Replication- Virus Replication
- Replication, Virus
- Replications, Virus
- Virus Replications
|
Below are MeSH descriptors whose meaning is more general than "Virus Replication".
Below are MeSH descriptors whose meaning is more specific than "Virus Replication".
This graph shows the total number of publications written about "Virus Replication" by people in this website by year, and whether "Virus Replication" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 1 | 3 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 2 | 3 |
| 1998 | 2 | 6 | 8 |
| 1999 | 3 | 3 | 6 |
| 2000 | 2 | 1 | 3 |
| 2001 | 2 | 6 | 8 |
| 2002 | 2 | 7 | 9 |
| 2003 | 5 | 9 | 14 |
| 2004 | 15 | 19 | 34 |
| 2005 | 17 | 22 | 39 |
| 2006 | 16 | 25 | 41 |
| 2007 | 10 | 12 | 22 |
| 2008 | 13 | 12 | 25 |
| 2009 | 6 | 13 | 19 |
| 2010 | 9 | 17 | 26 |
| 2011 | 10 | 13 | 23 |
| 2012 | 12 | 18 | 30 |
| 2013 | 19 | 21 | 40 |
| 2014 | 19 | 24 | 43 |
| 2015 | 18 | 12 | 30 |
| 2016 | 12 | 24 | 36 |
| 2017 | 128 | 217 | 345 |
| 2018 | 111 | 215 | 326 |
| 2019 | 29 | 85 | 114 |
| 2020 | 66 | 190 | 256 |
| 2021 | 54 | 157 | 211 |
| 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Virus Replication" by people in Profiles.
-
Host-dependent editing of SARS-CoV-2 in COVID-19 patients. Emerg Microbes Infect. 2021 Dec; 10(1):1777-1789.
-
The journey of SARS-CoV-2 in human hosts: a review of immune responses, immunosuppression, and their consequences. Virulence. 2021 12; 12(1):1771-1794.
-
Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infection. J Clin Invest. 2021 10 15; 131(20).
-
Captopril alleviates lung inflammation in SARS-CoV-2-infected hypertensive mice. Zool Res. 2021 Sep 18; 42(5):633-636.
-
Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1. Proc Natl Acad Sci U S A. 2021 09 14; 118(37).
-
SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway. J Virol. 2021 09 09; 95(19):e0086221.
-
DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitors. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
-
Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. Proc Natl Acad Sci U S A. 2021 09 07; 118(36).
-
Bithiazole Inhibitors of Phosphatidylinositol 4-Kinase (PI4KIIIß) as Broad-Spectrum Antivirals Blocking the Replication of SARS-CoV-2, Zika Virus, and Human Rhinoviruses. ChemMedChem. 2021 12 06; 16(23):3548-3552.
-
Evolution of viral variants in remdesivir-treated and untreated SARS-CoV-2-infected pediatrics patients. J Med Virol. 2022 01; 94(1):161-172.